• Assure Holdings (IOM) has expanded its operations with its first neuromonitoring case in Nevada
  • The company has signed an agreement to serve eight hospitals in the state
  • It is now operating in twelve states across the U.S.
  • Assure Holdings provides intraoperative neuromonitoring services during invasive surgeries
  • Assure Holdings (IOM) is unchanged trading at $9.30 per share

Assure Holdings (IOM) has expanded its operations with its first neuromonitoring case in Nevada.

It has signed an agreement to serve eight hospitals in the state, primarily in the Las Vegas Metro Area.

It will begin working with five surgeons that specialize in neurosurgery and orthopedic spine surgery who perform approximately 2,000 procedures per year. 

The company is now operating in twelve states: Colorado, Texas, Louisiana, Utah, Pennsylvania, Michigan, South Carolina, Arizona, Kansas, Missouri, Nebraska and Nevada.

John A. Farlinger, Assure’s Executive Chairman and CEO, stated,

“We expect to grow rapidly in Nevada and are confident in our ability to take advantage of sizeable business development opportunities in the state. On a per capita basis, Las Vegas is among the largest spine surgery markets in the nation. Over the next year, we anticipate that Nevada will be among Assure’s fastest-growing markets.”

Assure Holdings provides intraoperative neuromonitoring services during invasive surgeries.

Assure Holdings (IOM) is unchanged trading at $9.30 per share as of 10:45 am ET.

More From The Market Online

Avicanna launches 10% CBD (THC free) formula in Canada

Avicanna (TSX:AVCN) launches RHO Phyto Micro Drop 100, a 10 per cent CBD (THC free), proprietary oral formulation in Canada.

Theratechnologies phases down preclinical oncology research

Biopharmaceutical company Theratechnologies (TSX:TH) announced it will phase down its preclinical oncology research activities.